Deferred Tax Assets, Valuation Allowance of Xenon Pharmaceuticals Inc. from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Xenon Pharmaceuticals Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • Xenon Pharmaceuticals Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $346,794,000, a 30% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Xenon Pharmaceuticals Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $346,794,000 +$79,938,000 +30% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q4 2024 $266,856,000 +$52,414,000 +24% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q4 2023 $214,442,000 +$49,777,000 +30% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q4 2022 $164,665,000 +$35,571,000 +28% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q4 2021 $129,094,000 +$28,983,000 +29% 31 Dec 2021 10-K 29 Feb 2024 2023 FY
Q4 2020 $100,111,000 +$9,306,000 +10% 31 Dec 2020 10-K 01 Mar 2023 2022 FY
Q4 2019 $90,805,000 +$11,279,000 +14% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q4 2018 $79,526,000 +$11,901,000 +18% 31 Dec 2018 10-K 09 Mar 2020 2019 FY
Q4 2017 $67,625,000 +$9,210,000 +16% 31 Dec 2017 10-K 06 Mar 2019 2018 FY
Q4 2016 $58,415,000 +$6,897,000 +13% 31 Dec 2016 10-K 07 Mar 2018 2017 FY
Q4 2015 $51,518,000 +$2,482,000 +5.1% 31 Dec 2015 10-K 08 Mar 2017 2016 FY
Q4 2014 $49,036,000 -$2,364,000 -4.6% 31 Dec 2014 10-K 08 Mar 2016 2015 FY
Q4 2013 $51,400,000 31 Dec 2013 10-K 12 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.